BioSpace News Archive

Business

Canopy Growth and Molecular Science Corp. Announce Collaboration to Advance Cannabis Testing Across Canada

Standardized testing supports informed decisions for patients and producers

June 7, 2018
·
7 min read
Business

MiMedx to restate certain historical financial statements

Company to Restate Financial Statements for Fiscal Years 2012 through 2016, and Interim Periods of 2017 Related to Revenue Recognition

June 7, 2018
·
5 min read
Business

Bruker Announces Improved Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control, and Candida auris Testing at ASM 2018

Improved IR Biotyper™ system for fast, routine and cost-effective strain typing for hospital infection control and earlier detection of outbreaks

June 7, 2018
·
8 min read
Pharm Country

Evolving Treatment Strategies in Multiple Myeloma: Janssen’s Darzalex Leads a Host of Novel Agents in Redefining Treatment Strategies and Approaches

A new independent report from Spherix Global Insights examines the emerging trends and unveils near term shifts that are anticipated in this field which is experiencing its “golden age” of drug development.

June 7, 2018
·
4 min read
Business

TherapeuticsMD to Present at Goldman Sachs 39th Annual Global Healthcare Conference

Chief Executive Officer Robert G. Finizio will participate in the conference.

June 7, 2018
·
4 min read
Genetown

FDA, Bill & Melinda Gates Foundation and the Gates MRI Headline Final Day of BIO International Convention

Fireside chats with Dr. Scott Gottlieb, Dr. Sue Desmond-Hellman and Dr. Penny Heaton focus on U.S. and global healthcare challenges

June 7, 2018
·
3 min read
Business

Bristol-Myers Squibb to Announce Results for Second Quarter 2018 on July 26

During a conference call at 10:30 a.m. EDT on July 26, company executives will review financial information and will address inquiries from investors and analysts.

June 7, 2018
·
1 min read
Business

Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania

Expands Gene Therapy Portfolio with a Novel Mutation Independent Product Candidate for Autosomal Dominant Retinitis Pigmentosa

June 7, 2018
·
5 min read
Drug Development

ArQule to Present Clinical Data for its BTK Inhibitor, ARQ 531, at the 23rd Congress of the European Hematology Association (EHA)

ArQule, Inc. today announced clinical data from the company-sponsored ARQ 531-101 Phase 1 dose escalation study will be presented at the EHA Congress in Stockholm, Sweden.

June 7, 2018
·
5 min read
Drug Development

KaNDy Therapeutics Announces Positive Clinical Data with Lead Candidate NT-814 for the Treatment of Symptoms of the Menopause

Phase Ib/IIa data showed rapid and highly significant reductions in the frequency and severity of hot flashes and the number of night time awakenings

June 7, 2018
·
4 min read